A vaccination campaign is underway across England to provide free meningitis B (MenB) immunization to approximately one million young people. The initiative was prompted by an outbreak in Kent that resulted in 29 confirmed or suspected cases and two deaths. Nearly 90,000 doses have already been administered, with 135,000 additional appointments scheduled for the coming weeks.
The vaccine is being offered to two primary groups: 17 and 18-year-olds in sixth form, and students under age 25 beginning residential university or further education studies for the first time in autumn 2026. This includes international students and those from other UK nations studying in England. Eligible individuals born on or after July 21, 2001, can access walk-in services at participating pharmacies without requiring GP registration. Those aged 17 and 18 already registered with a GP can book through the NHS National Booking Service. The vaccine requires two doses administered at least 28 days apart for optimal protection.
MenB is a dangerous bacterial strain capable of causing meningitis, sepsis, and potentially fatal infections. Complications can include severe disabilities such as hearing loss, brain damage, and amputations. First-year university students face approximately seven times higher infection risk than non-university peers of similar age, largely due to increased social mixing and shared living arrangements. The infection spreads through close contact such as kissing, sharing drinks and vapes, and prolonged proximity.
The MenB vaccine was incorporated into the UK childhood immunization program for infants born on or after July 1, 2015, but teenagers and young adults over age 11 have not previously received routine vaccination. Common side effects include mild injection site reactions, fever, nausea, headache, or muscle aches, typically resolving within one to two days. Serious adverse effects are rare. Vaccine experts have recommended that government consider routinely offering MenB vaccination to all teenagers around age 15, though individual nations retain decision-making authority on this matter.
All UK nations are implementing vaccination programs, with variations in eligibility and access procedures. Most are offering the vaccine to students completing their final secondary education year in 2026, regardless of subsequent educational plans or current school enrollment status.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI